OSI Pharmacueticals

JP Morgan just issued an intra-day downgrade on shares of OSI Pharma, (Nasdaq: OSIP) following news that Astellas had launched a $52/share hostile bid for OSI. Morgan moved its investment rating on OSI Pharma from Overweight to Neutral. Astellas trades in Japan. OSI has rejected the offer. OSI...